Skip to main content
U.S. flag

An official website of the United States government

Fresenius Agrees to Pay $5.2 Million to Resolve Allegations that it Overbilled Medicare for Hepatitis B Tests

BOSTON - The United States Attorney's Office announced today that Fresenius Medical Care Holdings, Inc., d/b/a Fresenius Medical Care North America, Inc., the largest operator of kidney dialysis clinics in the United States, has agreed to pay $5.2 million to resolve allegations that the company tested dialysis patients for Hepatitis B surface antigen more frequently than medically necessary and then billed Medicare for the unnecessary tests.


Action Details

  • Date:October 9, 2019
  • Agency:U.S. Attorney
  • Enforcement Types:
    • Criminal and Civil Actions